DNA 合成市場規模、佔有率和成長分析（按產品、類型、方法、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年 DNA 合成市場規模價值為 45.6 億美元，預計將從 2024 年的 53.1 億美元成長到 2032 年的 180.3 億美元，預測期內（2025-2032 年）的複合年成長率為 16.5%。

受製藥、生物技術和基因研究領域的重要應用推動，全球 DNA 合成市場預計將經歷顯著成長。研究人員和生物技術公司擴大使用 DNA 合成服務來創建用於各種應用的 DNA 序列，包括藥物開發和基因工程。這種擴張進一步推動了對合成生物學工具的需求不斷成長、個人化醫療的進步以及基因編輯的創新。此外，DNA 合成服務有助於快速原型製作和實驗，促進創新並加速科學發現。隨著生物技術和醫療保健領域的進步，DNA 合成市場將在基因組學和分子生物學的進步中發揮重要作用，塑造這些領域的未來。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

DNA 合成市場規模（依產品/服務分類）及複合年成長率（2025-2032）

• 市場概況
• 裝置
• 試劑和耗材
• 服務

DNA 合成市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 寡核苷酸合成
• 基因合成

DNA 合成市場規模（依方法分類）及複合年成長率（2025-2032）

• 市場概況
• 固相合成
• 基於PCR的酶合成
• 基於晶片的合成

DNA 合成市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 診斷
  • 感染疾病
  • 癌症
• 治療
  • 基因治療
  • 預防醫學
• 研究與開發
  • 克隆和基因編輯
  • 藥物研發

DNA 合成市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 製藥和生物技術公司
• 合約研究組織 (CRO)
• 合約開發與製造組織 (CDMO)
• 學術研究所

DNA 合成市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific（USA）
• Twist Bioscience（USA）
• BIONEER Corporation（South Korea）
• Eton Bioscience, Inc.（USA）
• LGC Biosearch Technologies（UK）
• IBA Lifesciences GmbH（Germany）
• Eurofins Scientific（Luxembourg）
• Integrated DNA Technologies, Inc.（USA）
• Quintara Biosciences（USA）
• GenScript（China）
• Bio Basic Inc.（Canada）
• OriGene Technologies, Inc.（USA）
• Synbio Technologies（USA）
• GeneArt（Germany）
• Genewiz（USA）
• Sangon Biotech（China）
• Creative Biogene（USA）
• BaseClear BV（Netherlands）
• BioCat GmbH（Germany）

結論和建議

DNA Synthesis Market size was valued at USD 4.56 billion in 2023 and is poised to grow from USD 5.31 billion in 2024 to USD 18.03 billion by 2032, growing at a CAGR of 16.5% during the forecast period (2025-2032).

The global DNA synthesis market is poised for substantial growth, driven by its essential applications across pharmaceuticals, biotechnology, and genetics research. Increasingly, researchers and biotech firms are leveraging DNA synthesis services to create tailored DNA sequences for various uses, including drug development and genetic engineering. This expansion is further propelled by the escalating demand for synthetic biology tools, advancements in personalized medicine, and innovations in gene editing. Additionally, DNA synthesis services facilitate rapid prototyping and experimentation, promoting innovation and speeding up scientific discoveries. As the biotechnology and healthcare sectors progress, the DNA synthesis market is set to play a crucial role in advancing genomics and molecular biology, shaping the future of these fields.

Top-down and bottom-up approaches were used to estimate and validate the size of the Dna Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Dna Synthesis Market Segments Analysis

Global DNA Synthesis Market is segmented by Product, Type, Method, Application, End-user and region. Based on Product, the market is segmented into Instruments, Reagents & Consumables and Services. Based on Type, the market is segmented into Oligonucleotide Synthesis and Gene Synthesis. Based on Method, the market is segmented into Solid-phase Synthesis, PCR-based Enzyme Synthesis and Chip-based Synthesis. Based on Application, the market is segmented into Diagnostics, Therapeutics and Research & Development. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Dna Synthesis Market

One of the primary catalysts for growth in the DNA synthesis market is the ongoing progress in genetic engineering technologies. Breakthroughs such as CRISPR-Cas9 and various gene-editing methods have greatly boosted the demand for customized DNA sequences. This heightened need is primarily driven by researchers and biotechnology firms that rely on specific and tailored DNA constructs for their experiments and applications. Consequently, DNA synthesis has become an essential element of innovative genetic engineering initiatives, facilitating the advancement of research and applications in diverse fields, including medicine, agriculture, and industrial biotechnology. This trend underscores the pivotal role of DNA synthesis in scientific advancement.

Restraints in the Dna Synthesis Market

A significant challenge facing the DNA synthesis market is the stringent regulatory framework governing the synthesis and application of genetic materials. Regulations and oversight, especially related to gene editing and biotechnology, can hinder market access and impede research and development initiatives. While these regulations are crucial for ensuring ethical practices and safety, they can create obstacles for companies operating within this sector. The necessity to comply with complex legal requirements can slow innovation and make it difficult for businesses to navigate the evolving landscape of DNA technology, ultimately impacting their competitiveness and growth prospects.

Market Trends of the Dna Synthesis Market

The DNA synthesis market is experiencing notable growth driven by advancements in gene editing technologies, particularly CRISPR-Cas9. These innovations are significantly enhancing the precision of genetic modifications across various sectors, including therapeutics, agriculture, and synthetic biology. As the demand for custom DNA sequences escalates, fueled by the increasing accessibility and versatility of gene editing tools, the market is set to expand further. Companies in the biotech and pharmaceutical industries are seeking tailored DNA solutions to advance research and product development, making the DNA synthesis market a dynamic landscape poised for sustained evolution and investment opportunities.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global DNA Synthesis Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Consumables
• Services

Global DNA Synthesis Market Size by Type & CAGR (2025-2032)

• Market Overview
• Oligonucleotide Synthesis
• Gene Synthesis

Global DNA Synthesis Market Size by Method & CAGR (2025-2032)

• Market Overview
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis

Global DNA Synthesis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
  • Infectious Diseases
  • Cancer
• Therapeutics
  • Gene Therapy
  • Preventive Medicine
• Research & Development
  • Cloning and Gene Editing
  • Drug Discovery & Development

Global DNA Synthesis Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)
• Academic & Research Institutes

Global DNA Synthesis Market Size & CAGR (2025-2032)

• North America (Product & Service, Type, Method, Application, End-user)
  • US
  • Canada
• Europe (Product & Service, Type, Method, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type, Method, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type, Method, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type, Method, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIONEER Corporation (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eton Bioscience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA Lifesciences GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quintara Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Basic Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synbio Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneArt (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangon Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BaseClear B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCat GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations